08:00 , Dec 14, 2015 |  BC Week In Review  |  Company News

Bioaster, Cancer Research Center of Lyon, J&J deal

Bioaster, the center and Johnson & Johnson’s Janssen-Cilag S.A.S. company partnered to conduct preclinical R&D of immunotherapeutic treatments for chronic HBV infection. The deal term is two years. Bioaster , Lyon, France   Cancer Research...
07:00 , Jul 18, 2013 |  BC Innovations  |  Distillery Therapeutics

Indication: Cancer

This week in therapeutics Indication Target/marker/pathway Summary Licensing status Publication and contact information Cancer Breast cancer Toll-like receptor 7 (TLR7) Mouse studies suggest stimulating TLR7 on plasmacytoid dendritic cells (pDCs) could help treat breast cancer....